Monitoring of human immunodeficiency virus infection in resource-constrained countries.
about
Comparison of two human immunodeficiency virus (HIV) RNA surrogate assays to the standard HIV RNA assayThe Diagnosis of HIV Infection in Infants and ChildrenLaboratory support of global health researchMicroflow cytometers with integrated hydrodynamic focusing.Exclusion-Based Capture and Enumeration of CD4+ T Cells from Whole Blood for Low-Resource Settings.HIV-1 viral load assays for resource-limited settings.A microfluidic device for practical label-free CD4(+) T cell counting of HIV-infected subjects.Comparison of a new, affordable flow cytometric method and the manual magnetic bead technique for CD4 T-lymphocyte counting in a northern Nigerian setting.Enhancing the performance of a point-of-care CD4+ T-cell counting microchip through monocyte depletion for HIV/AIDS diagnostics.Transfer and evaluation of an automated, low-cost real-time reverse transcription-PCR test for diagnosis and monitoring of human immunodeficiency virus type 1 infection in a West African resource-limited setting.CD4 criteria improves the sensitivity of a clinical algorithm developed to identify viral failure in HIV-positive patients on antiretroviral therapy.HPTN 062: a feasibility and acceptability pilot intervention to reduce HIV transmission risk behaviors among individuals with acute and early HIV infection in Lilongwe, Malawi.Total lymphocyte count as a surrogate marker for CD4 count in resource-limited settings.A simple manual rosetting method for absolute CD4+ lymphocyte counting in resource-limited countriesPrevalence of anaemia and immunological markers among ghanaian HAART-naïve HIV-patients and those on HAART.Systematic review of the performance of HIV viral load technologies on plasma samples.Comparison of capillary based microflurometric assay for CD4+ T cell count estimation with dual platform Flow cytometry.Current practices in laboratory monitoring of HIV infection.Low-cost assays for monitoring HIV infected individuals in resource-limited settings.Evaluation of antiretroviral therapy results in Blantyre, Malawi.Feasibility of detecting human immunodeficiency virus type 1 drug resistance in DNA extracted from whole blood or dried blood spots.Total Lymphocyte Count as surrogate marker for CD4 Cell Count in HIV-Infected Individuals in Gondar University Hospital, Northwest EthiopiaCan HIV reverse transcriptase activity assay be a low-cost alternative for viral load monitoring in resource-limited settings?Field evaluation of a broadly sensitive HIV-1 in-house genotyping assay for use with both plasma and dried blood spot specimens in a resource-limited country.When to Monitor CD4 Cell Count and HIV RNA to Reduce Mortality and AIDS-Defining Illness in Virologically Suppressed HIV-Positive Persons on Antiretroviral Therapy in High-Income Countries: A Prospective Observational StudyMicrofluidic differential immunocapture biochip for specific leukocyte countingDevelopment and evaluation of a clinical algorithm to monitor patients on antiretrovirals in resource-limited settings using adherence, clinical and CD4 cell count criteria.Evaluation of Dynabeads and Cytospheres compared with flow cytometry to enumerate CD4+ T cells in HIV-infected Ugandans on antiretroviral therapyEvaluation of the Cavidi ExaVir Load assay (version 3) for plasma human immunodeficiency virus type 1 load monitoring.Assessment of the low-cost Cavidi ExaVir Load assay for monitoring HIV viral load in pediatric and adult patients.Immuno-haematologic and virologic responses and predictors of virologic failure in HIV-1 infected adults on first-line antiretroviral therapy in Cameroon.Utility of total lymphocyte count as a surrogate for absolute CD4 count in the adult Indian HIV population: A prospective study.The performance of reverse transcriptase assay for the estimation of the plasma viral load in HIV-1 and HIV-2 infections.A microflow cytometer exploited for the immunological differentiation of leukocytes.QASI: A collaboration for implementation of an independent quality assessment programme in India.Super RLuc8-sFv; a new luciferase-labeled probe for detection of human CD4+ cells.Prevalence and management of helminthiasis among underfives living with HIV/AIDS at Amana Hospital, Tanzania.Use of surrogate markers to predict the HIV disease stage and time to initiate antiretroviral therapy in developing countries.
P2860
Q24535105-C0AB9623-7BBA-4F7B-BEA9-B444EDFEB1E3Q26738645-0ED2754F-EEA3-4B1B-AF53-67913088C044Q28681945-AC619804-1CE8-4790-9087-6346A1EBF47DQ30453368-7DC6E975-7431-4925-B8E3-D2D451EBEB42Q30616783-A17CE420-AAC3-407C-AB89-ED12AD0306C4Q33259966-18ABD97A-B451-43A0-89FD-04FF11B23EC5Q33271334-5C75C848-C66C-44D6-8EEE-50147DF294B9Q33593827-1001E5A0-01DC-4A25-A940-B23CA451256BQ33780824-DF7AAE31-61C8-408B-9493-0BAEC3F388BEQ33856274-926BBD83-B5E9-4A36-B5F3-F66FB3D41787Q34195328-123699F1-33FA-4627-A058-F66FE65E30D1Q34279946-AE39AB29-C029-44F4-94F0-A3A19743A1EDQ34296369-75B83551-9138-4C51-B91E-9BE43F553106Q34601477-01054E9F-CB4D-482B-B354-F80A5D833D7FQ34973435-CD94D0E3-3967-4C16-B45E-9F394C93AE3EQ35099443-1A2EC21F-1518-49E2-AC55-D27DEFFAFF73Q35129695-E3890E75-D8A0-43C0-98EC-EA0551371A86Q35770853-AE234A35-AC44-4D37-A710-F26B788DB378Q35770858-20256CEA-0674-4DCF-B39F-19BAB668F4F2Q35937624-19AF4318-D44B-44C9-86E9-3E9B6AB1E4F4Q36098805-958766C4-8FA4-4D75-AE6A-E235C0A95442Q36467566-636CA0E3-FF54-4D14-9716-1640D4721CADQ36526686-2714C56A-FE25-46C5-9519-EB9A0C6DB870Q36558961-B594A971-917A-4195-BFB5-FA82B4807D87Q36900879-3842F105-983C-4BA4-ADA3-7397CC80D4E2Q36969448-226F2A8F-1ECC-44F5-B44A-50A13E239337Q37147686-543F490E-0D1A-4D15-B0E7-AA97E67EBA0AQ37149013-F1BF4622-C8F3-4A39-89EB-25404E4EA1A8Q37333664-0A1BBC6D-0E72-41A6-AF5F-802A8B3C8008Q37441641-FAB4CD90-772E-430C-B28F-794F6C324805Q37579676-EC5C6DC4-3CB2-4A8A-A826-BFD24178B4F8Q37634747-A7A9A404-0C91-47E1-8599-B2BCD6E39D69Q38384495-FFC95351-76D1-4FF1-B8A1-9CE82996A7CEQ39745776-3F03B4CE-A735-4E8A-8CF9-3094EA1CA7E9Q40063292-FC2CF31F-65C7-4409-9EA7-884DB24FC84AQ40362118-2DCC77F8-C534-497E-A642-18FE9BAAAC8EQ43938747-778892C1-D143-4D93-BB82-48B155DBD800Q51122325-C500B3BE-00C0-4419-A9D7-51C01F227769
P2860
Monitoring of human immunodeficiency virus infection in resource-constrained countries.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Monitoring of human immunodeficiency virus infection in resource-constrained countries.
@ast
Monitoring of human immunodeficiency virus infection in resource-constrained countries.
@en
type
label
Monitoring of human immunodeficiency virus infection in resource-constrained countries.
@ast
Monitoring of human immunodeficiency virus infection in resource-constrained countries.
@en
prefLabel
Monitoring of human immunodeficiency virus infection in resource-constrained countries.
@ast
Monitoring of human immunodeficiency virus infection in resource-constrained countries.
@en
P2093
P356
P1476
Monitoring of human immunodeficiency virus infection in resource-constrained countries.
@en
P2093
Amanda Dunne
Robert Oelrichs
Shannon Turnbull
Suzanne Crowe
P304
P356
10.1086/375369
P407
P433
P577
2003-07-01T00:00:00Z